Stephen Berenson
Managing Partner at Flagship Pioneering
Cambridge, Massachusetts
Writes $500K – $15M checks · typically $7M
About
Stephen Berenson, MIT-trained mathematician with 33 years at J.P. Morgan (12 as vice chairman), applies capital-markets expertise to building biotech, structuring large deals like Samsung, and supports unconventional math research.
Moderna @moderna_tx
Today we reported financial results and provided business updates for the second quarter of 2026. Read more: https://t.co/rW0gQuG256 https://t.co/vUztjAuTUX

Jul 31, 2026 · ♥ 10 · ⇄ 1
Moderna @moderna_tx
Today we announced the dosing of the first U.S. participant in our Phase 1 study evaluating mRNA-4200, a tumor-targeted cancer antigen therapy candidate, in patients with advanced or metastatic solid tumors. Read more: https://t.co/2UUO0m79OY https://t.co/Wq7xZ7b3Ep

Jul 16, 2026 · ♥ 20 · ⇄ 6
Moderna @moderna_tx
At Moderna, our Mission is to deliver the greatest possible impact to people through mRNA medicines. In pursuit of this, we remain focused on advancing our science, supporting our people, and delivering for patients, communities, and the environment. Our latest Impacting Human https://t.co/crv6Pvcquh

Jul 14, 2026 · ♥ 17 · ⇄ 4
Invests in
AgTechAI & Machine LearningBiotechClimate TechFoodTechHealthtech
Deals · 1
Cibo TechnologiesBoard seat
via Flagship Pioneering · filed Jan 2020 · $15M raise
Attribution from SEC filings, press coverage, and firm rosters.
